₹ 50.13
-2.63 (-4.98%)
BSE
G
Genomic Valley Biotech
₹ 50.13
BSE
Genomic Valley Biotech Fundamentals
Company Valuation
Market Cap (₹ Cr.)
15
PE Ratio
-5,276.00
PB Ratio
4.11
Dividend Yield
-
ROE
9.13%
ROCE
11.32%
Book Value (₹)
12.84
Face Value (₹)
10.00
Analyse GVBL with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 46.72% | 46.06% | 46.06% | 46.06% | 46.06% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 52.53% | 52.25% | 51.01% | 50.82% | 50.91% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GVBL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
539206
NSE Scrip Name
GVBL
ISIN
INE574D01010

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






